Navigation Links
Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression

Researchers have found that Migration/Macrophage Inhibitory factor (MIF) which is an immune cell responsible for progression of Multiple Sclerosis. This new pathway can be used in finding drugs which reduces the amount of MIF // in a way progression of Multiple Sclerosis is hindered.

Multiple Sclerosis:

Multiple Sclerosis is an autoimmune disease which is caused by non-recognizing of its own body cells by the immune system leading to an immune response of activating immune cells against the body’s own cells. In Multiple Sclerosis the immune cells produces an immune response against the myelin sheath that surrounds nerve fibers in the brain and spinal cord and enables them to transmit impulses. MS shows a pattern of remission and relapse with no warning as to when a relapse will occur.

Migration Inhibiton Factor – Multiple Sclerosis:

Professor Caroline Whitacre and team from Ohio State University have found that Migration/Macrophage Inhibition Factor stimulates a chain of reactions that lead to the production of inflammation-producing chemicals. Conversely, lack of MIF seems to trigger the release of other immune system chemicals that block inflammation.

Researchers are confident that blocking the molecule macrophage migration inhibitory factor it will be possible for treatment of Multiple Sclerosis.

Experts View:

Professor Caroline Whitacre said, "Our results suggest that MIF may be less important for initiating MS, but that it may be necessary for MS progression and the levels of MIF can be used as an indicator of multiple sclerosis disease progression. But more importantly, perhaps this study will lead to drugs that can halt the course of MS by blocking the action of MIF."

Mike O'Donovan, chief executive Multiple Sclerosis Society said, "The possibility that a way might be found to stop MS in its tracks is obviously encouraging and needs investigating further.

Helen Yates, Multiple Sclerosis Resource Centre said, "Whilst this study is only at the animal model stage, the identification of this potential gene factor in relation to MS is extremely interesting and offers great hope for the future."

Source: BBC News.
'"/>




Related medicine news :

1. Lymph Cell Growth In Eyes Related To Macrophages
2. Risk Factors for vision problems in Diabetes
3. Age-Related Macular Degeneration - Risk Factors
4. Factors That Might Increase The Risk Of Schizophrenia
5. Evaluating The Risk Factors Of Osteoporosis
6. Elevated Blood Sugar Levels A Risk Factor Of Heart Disease
7. Obesity A Risk Factor For Stroke
8. Risk Factors For Stroke Studied
9. Analyzing The Risk Factors For Diabetic Neuropathy
10. Heart Disease Risk Factors Found To Increase Risk of Dementia In Old Age
11. Environmental Factors Found To Have An Impact On The Sex of A Child
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... york (PRWEB) , ... April 28, 2017 , ... ... to announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under ... and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to ... Care Medicine will host industry leaders for the annual spring Convention & Expo, ... the industry adapt to the issues currently affecting urgent care and on-demand healthcare. ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... NuevaCare, ... cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information ... interested persons to bookmark and read organized content on topics such as home care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
Breaking Medicine Technology: